Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study).
about
Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial.Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis.Medications that cause weight gain and alternatives in Canada: a narrative reviewBioactive Peptides from Germinated Soybean with Anti-Diabetic Potential by Inhibition of Dipeptidyl Peptidase-IV, α-Amylase, and α-Glucosidase Enzymes
P2860
Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy and safety of saxagli ...... olled study (the SMART study).
@en
Efficacy and safety of saxagli ...... el randomized controlled study
@nl
type
label
Efficacy and safety of saxagli ...... olled study (the SMART study).
@en
Efficacy and safety of saxagli ...... el randomized controlled study
@nl
prefLabel
Efficacy and safety of saxagli ...... olled study (the SMART study).
@en
Efficacy and safety of saxagli ...... el randomized controlled study
@nl
P2093
P2860
P356
P1476
Efficacy and safety of saxagli ...... olled study (the SMART study).
@en
P2093
Fengmei Xu
Xueying Wang
P2860
P304
P356
10.1111/DOM.12942
P50
P577
2017-03-14T00:00:00Z